Reckitt Benckiser Aktie WKN: A0M1W6 / ISIN: GB00B24CGK77

72,92EUR
-1,56EUR
-2,09%
11:26:16
62,10GBP
-0,50GBP
-0,80%
12:07:22
Diese Aktie kaufen
mehr Daten anzeigen
Werbung

Reckitt Benckiser Aktien News

04.02.21
Unilever in ‘good shape’ for 2021 despite sliding revenue and profit (Belfast Telegraph)
02.03.21
Merck to help produce Johnson & Johnson vaccine to speed up supply (Belfast Telegraph)
04.02.21
Merck loses $2.1B in Q4; longtime CEO Frazier to retire (EN, Chinapost)
24.02.21
Syracuse's heart: PG, cancer survivor Tiana Mangakahia (EN, Chinapost)
01.03.21
Cardinals agree to terms with free agent edge rusher JJ Watt (EN, Chinapost)
02.03.21
Official: Merck to help produce rival J&J's COVID-19 vaccine (EN, Chinapost)
02.03.21
VIRUS TODAY: Merck to produce J&J shot, Dems set to debate (EN, Chinapost)
09.02.21
Colgate-Palmolive Presents at The Consumer Analyst Group of New York Virtual Conference (EN, Colgate-Palmolive)
02.02.21
Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU (EN, Johnson & Johnson)
03.02.21
Johnson & Johnson to Participate in the Raymond James 42nd Annual Institutional Investors Conference (EN, Johnson & Johnson)
03.02.21
REVEAL Lite 2 Risk Calculator Offers Simplified Model to Assess One-Year Mortality Risk Status in Patients with Pulmonary Arterial Hypertension (PAH) (EN, Johnson & Johnson)
04.02.21
Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate (EN, Johnson & Johnson)
05.02.21
Johnson & Johnson to Participate in the Cowen 41st Annual Health Care Virtual Conference (EN, Johnson & Johnson)
08.02.21
SPRAVATO® (Esketamine Nasal Spray) Authorised in Europe for the Rapid Reduction of Depressive Symptoms in a Psychiatric Emergency for Patients with Major Depressive Disorder (EN, Johnson & Johnson)
08.02.21
Janssen Presents Results from Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA® (apalutamide) and ZYTIGA® (abiraterone acetate) Combination (EN, Johnson & Johnson)
08.02.21
Janssen Announces Treatment with ERLEADA® (apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer (EN, Johnson & Johnson)
16.02.21
Johnson & Johnson Announces Submission of European Conditional Marketing Authorisation Application to the EMA for its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate (EN, Johnson & Johnson)
19.02.21
Johnson & Johnson Announces Submission to World Health Organization for Emergency Use Listing of Investigational Single-Shot Janssen COVID-19 Vaccine Candidate (EN, Johnson & Johnson)
26.02.21
Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee (EN, Johnson & Johnson)
28.02.21
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use (EN, Johnson & Johnson)
28.02.21
Johnson & Johnson Announces U.S. CDC Advisory Committee Recommends First Single-Shot COVID-19 Vaccine for Adults 18 and Older in U.S. (EN, Johnson & Johnson)
02.03.21
Johnson & Johnson Statement on Collaboration with Merck (EN, Johnson & Johnson)
04.02.21
Unilever restores targets as China and India boost sales (Financial Times)
04.02.21
Unilever restores growth targets (Financial Times)
04.02.21
Merck chief Kenneth Frazier to retire this summer (Financial Times)
04.02.21
Unilever: squeeze in (Financial Times)
05.02.21
The shackles are off: Unilever goes for growth after UK move (Financial Times)
02.03.21
Merck to manufacture Johnson & Johnson vaccine (Financial Times)
03.02.21
Merck Q4 Earnings Preview: Keytruda And Gardasil In Focus (Forbes)
11.02.21
Here’s Why Merck Is A Better Pick Over Johnson & Johnson Stock (Forbes)
04.03.21
Colgate Palmolive Stock: A Smart Buy? (Forbes)
25.02.21
Merck to buy drug developer Pandion Therapeutics for $1.85B (FOX Business)
04.02.21
Unilever PLC : Final Results (Investegate)
09.02.21
Unilever PLC : Director/PDMR Shareholding (Investegate)
12.02.21
Beiersdorf Aktiengesellschaft : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
17.02.21
Merck KGaA : Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] (Investegate)
17.02.21
Merck KGaA : Preliminary announcement of the publication of quarterly reports and quarterly/interim statements (Investegate)
18.02.21
Unilever PLC : Board changes (Investegate)
22.02.21
Unilever PLC : Director/PDMR Shareholding (Investegate)
25.02.21
Beiersdorf Aktiengesellschaft : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
Seite: 12

Reckitt Benckiser News

Reckitt Benckiser News: auf dieser Seite finden Sie alle Reckitt Benckiser News und Nachrichten zur Reckitt Benckiser Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Reckitt Benckiser News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Reckitt Benckiser News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln